COST-UTILITY ANALYSIS OF LIRAGLUTIDE VERSUS GLIMEPIRIDE AS ADD-ON TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES IN CHINA

被引:1
|
作者
Gao, L. [1 ]
Li, S. C. [1 ]
机构
[1] Univ Newcastle, Callaghan, NSW 2308, Australia
关键词
D O I
10.1016/j.jval.2012.08.358
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A663 / A663
页数:1
相关论文
共 50 条
  • [41] Efficacy and safety of supaglutide as add-on to metformin in patients with type 2 diabetes
    Anwar, D.
    Bao, Y.
    Zhou, Y.
    Chen, S.
    Zhou, J.
    Li, L.
    Cheng, Z.
    Dong, X.
    Shi, X.
    Zhao, N.
    Yang, Y.
    Ma, J.
    Li, Y.
    Wang, Q.
    Jia, W.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S322 - S322
  • [42] Efficacy and Safety of Supaglutide as Add-on to Metformin in Patients with Type 2 Diabetes
    Anwar, Dilbar
    Bao, Yuqian
    Zhou, Yue
    Chen, Si
    Zhou, Jian
    Li, Liang
    Cheng, Zhifeng
    Dong, Xiaolin
    Shi, Xiaoxia
    Su, Xiuhai
    Li, Liping
    Wang, Haifang
    Wang, Yihua
    Li, Shu
    Li, Qingju
    Li, Xing
    Liu, Ming
    Sun, Jiao
    Zhao, Naiqing
    Yang, Yehong
    Ma, Jianhua
    Li, Yiming
    Wang, Qinghua
    Jia, Weiping
    DIABETES, 2023, 72
  • [43] Type 2 diabetes: which drug as add-on to metformin?
    Madsbad, Sten
    LANCET, 2012, 379 (9833): : 2222 - 2223
  • [44] Empagliflozin as add-on to metformin in people with Type 2 diabetes
    Merker, L.
    Haering, H-U.
    Christiansen, A. V.
    Roux, F.
    Salsali, A.
    Kim, G.
    Meinicke, T.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2015, 32 (12) : 1555 - 1567
  • [45] Vildagliptin add-on to metformin versus metformin uptitration in Chinese patients with type 2 diabetes: A sub-group analysis of the VISION study
    Ji, Linong
    Pan, Changyu
    Lu, Juming
    Zhu, Dalong
    Li, Hong
    Li, Qiang
    Li, Qifu
    Peng, Yongde
    Tian, Haoming
    Yao, Chen
    Zhao, Zhigang
    Wang, Binhui
    Cai, Qin
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 : 1 - 1
  • [46] Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus
    Kikuchi, Masatoshi
    Haneda, Masakazu
    Koya, Daisuke
    Tobe, Kazuyuki
    Onishi, Yukiko
    Couturier, Andre
    Mimori, Nobuyuki
    Inaba, Yoko
    Goodman, Matthew
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 89 (03) : 216 - 223
  • [47] Linagliptin versus glimepiride add-on for the long-term treatment of Type 2 diabetes mellitus
    Chilton, Robert
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (04) : 345 - 349
  • [48] Comparison between the Therapeutic Effect of Metformin, Glimepiride and Their Combination as an Add-On Treatment to Insulin Glargine in Uncontrolled Patients with Type 2 Diabetes
    Park, Cheol-Young
    Kang, Jun Goo
    Chon, Suk
    Noh, Junghyun
    Oh, Seung Joon
    Lee, Chang Beom
    Park, Sung Woo
    PLOS ONE, 2014, 9 (03):
  • [49] Comparative, Transversal Analysis of Adding Metformin or Glimepiride Therapy to Liraglutide in the Treatment of Type 2 Diabetes
    Courreges, Jean-Pierre
    Thiriet, Catherine M.
    Abbed, Nejma S.
    DIABETES, 2010, 59 : A201 - A201
  • [50] Results of a Model Analysis of the Cost-Effectiveness of Liraglutide Versus Exenatide Added to Metformin, Glimepiride, or Both for the Treatment of Type 2 Diabetes in the United States
    Lee, Won Chan
    Conner, Christopher
    Hammer, Mette
    CLINICAL THERAPEUTICS, 2010, 32 (10) : 1756 - 1767